Docenti

Isabella Merante Boschin

Associate Professor

Telefono: 3402701014

Phone lab: +39 0498212920

E-mail: isabella.meranteboschin@unipd.it

Career/Employment
2022- actually: Associate Professor MED/18-General Surgery, University of Padova
2012-2022: Adjunct Professor MED/18-General Surgery, University of Padova
2007-2022: Confirmed University Researcher MED/18. General Surgery, University of Padova
2018-2019: Level II Master's Degree in Pituitary and Adrenal Disease, University of Padova
2008-2009: PhD in Oncology and Surgical Oncology, cycle XXII, University of Padova
2000-2006: Specialist in General Surgery, University of Padova
1993-2000: University degree in Medicine and Surgery, University of Padova

Positions
Associate Professor MED/18-General Surgery, University of Padova
MD Endocrinology Unit, University of Padova – Padova Hospital

I was routinely involved in clinical and surgical activities mainly involving endocrine surgery from 1999 to November 2015. Since December 2015 I have been providing patient care at the University of Padova’s Endocrinology Unit.

As part of my research I have focused on diseases of the thyroid and parathyroid glands. As concerns malignant thyroid diseases, I have taken part in multidisciplinary studies on the diagnosis, treatment and follow-up of thyroid carcinomas. I have studied “sentinel” lymph node (radionuclide and vital stain) method applied to the treatment of differentiated thyroid carcinoma with a view to modulating the extent of lymph node dissection. I have taken part in studies on the characterization of malignant and potentially malignant thyroid nodes based on immunocytological methods (galectin-3) and molecular biology (BRAF, RAS), in cooperation with colleagues at the University of Padova’s Endocrinology and Pathological Anatomy Units. As concerns medullary thyroid carcinoma (MTC), sporadic or associated with multiple endocrine syndromes types IIa and IIb I have taken part in epidemiological, clinical, histopathological and immunohistochemical studies. I have been involved in studies on primary and secondary hyperparathyroidism, and on parathyroid carcinoma.

Since 2015 I have been particularly involved in ultrasound (US) diagnostic method and US-guided fine needle aspiration in the neck endocrinological diseases and moreover since 2019 in US guided minimally invasive treatment of thyroid nodes.

My scientific activity is documented by 80 scientific papers. I have given presentations at numerous national and international conferences.

Estrogen and thyroid cancer is a stem affair: A preliminary study. Zane M, Parello C, Pennelli G, Townsend DM, Merigliano S, Boscaro M, Toniato A, Baggio G, Pelizzo MR, Rubello D, Boschin IM. Biomed Pharmacother. 2017 Jan;85:399-411.

Aberrant right subclavian artery ("arteria lusoria") without the known associated nerve anomaly: an "anomaly of the anomaly"? A clinical case and review of the literature. Pelizzo MR, Boschin IM, Chondrogiannis S, Giammarile F, Colletti PM, Rubello D. Surg Radiol Anat. 2017 Mar 20.

Specifying the molecular pattern of sporadic parathyroid tumorigenesis-The Y282D variant of the GCM2 gene. Marchiori E, Pelizzo MR, Herten M, Townsend DM, Rubello D, Boschin IM. Biomed Pharmacother. 2017 Aug;92:843848

Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study. Ceccato F, Tizianel I, Voltan G, Maggetto G, Merante Boschin I, Quaia E, Crimì F, Scaroni C. Front Endocrinol (Lausanne). 2021 Dec 2;12:794197. doi: 10.3389/fendo.2021.794197

Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling. Galuppini F, Censi S, Merante Boschin I, Fassan M, Sbaraglia M, Valeri N, Hahne JC, Bertazza L, Munari G, Galasso M, Cascione L, Barollo S, Rugge M, Vianello F, Dei Tos AP, Mian C, Pennelli G Front Endocrinol (Lausanne). 2022 Feb 23;13:834075. doi: 10.3389/fendo.2022.834075. eCollection 2022.PMID: 35282462

Sentinel lymph node mapping: current applications and future perspectives in thyroid carcinoma. Boschin IM, Bertazza L, Scaroni C, Mian C, Pelizzo MR.Front Med (Lausanne). 2023 Oct 24;10:1231566. doi: 10.3389/fmed.2023.1231566. eCollection 2023.PMID: 37942415

Medullary thyroid carcinoma.Pelizzo MR, Mazza EI, Mian C, Merante Boschin I.Expert Rev Anticancer Ther. 2023 Jul-Dec;23(9):943-957. doi: 10.1080/14737140.2023.2247566. Epub 2023 Aug 30.PMID: 37646181 Review.

Parathyroid Retrospective Analysis of Neoplasms Incidence (pTRANI Study): An Italian Multicenter Study on Parathyroid Carcinoma and Atypical Parathyroid Tumour. Gurrado A, Pasculli A, Avenia N, Bellantone R, Boniardi M, Merante Boschin I, Calò PG, Camandona M, Cavallaro G, Cianchi F, Conzo G, D'Andrea V, De Crea C, De Pasquale L, Del Rio P, Di Meo G, Dionigi G, Dobrinja C, Docimo G, Famà F, Galimberti A, Giacomelli L, Graceffa G, Iacobone M, Innaro N, Lombardi CP, Materazzi G, Medas F, Mullineris B, Oragano L, Palestini N, Perigli G, Pezzolla A, Prete FP, Raffaelli M, Renzulli G, Rosato L, Scerrino G, Sgaramella LI, Sorrenti S, Testini C, Veroux M, Gasparri G, Testini M; pTRANI Study Group.J Clin Med. 2023 Sep 29;12(19):6297. doi: 10.3390/jcm12196297.PMID: 37834940

Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma. Censi S, Galuppini F, Clausi C, Battheu F, Manso J, Piva I, Corvaglia S, Pedron MC, Mondin A, Iacobone M, Torresan F, Merante Boschin I, Bertazza L, Barollo S, Pennelli G, Mian C.Thyroid. 2024 Dec 27. doi: 10.1089/thy.2023.0482. Online ahead of print.PMID: 38047536

Women with Autoimmune Thyroiditis Taking Levothyroxine During pregnancy: is iodine supplementation needed? Censi S, Messina G, Feligiotti E, Clausi C, Piva I, Basso D, Merante Boschin I, Bertazza L, Battheu F, Barollo S, Camilot M, Mian C. Nutrients. 2025 Jan 31;17(3):542. Doi:10.3390/nu17030542. PMID:39940399.